DNA/RNA Extraction Kit Market - Growth, Trends, COVID-19 Impact, and Forecast (2021-2026)

The DNA/RNA Extraction Kit Market is Segmented by Product (Cell-free DNA, Sequence-specific DNA, Sequence-specific RNA, Total RNA, and Other Products), Application (Hospitals, Diagnostics Centers, and Research Institutions), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The Report Offers the Value (in USD million) for the Above Segments.

Market Snapshot

Market Summary
Study Period: 2018-2026
Base Year: 2020
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 7.26 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The DNA/RNA extraction kit market is expected to register a CAGR of 7.26% during the forecast period of 2021-2026.

The COVID-19 pandemic impacted the DNA/RNA extraction kit market for the short time being due to restrictions on different business and research activities. Additionally, the diagnostics tests of other diseases and medical disorders in the hospitals and other clinical diagnostics establishments were affected due to a decrease in the turnout of the patients for tests because of COVID-19. However, the high infection rate of COVID-19 and research activities by key companies in the area of sequencing to expand their knowledge about the virus and its origin, along with molecular diagnostics of the SARS-CoV-2 virus, led to the development and launch of many DNA and RNA based COVID-19 kits, which proved to be very crucial and were in huge demand later. For instance, in April 2020, PHASE Scientific announced the commercial launch of the PHASIFY VIRAL RNA extraction kit for the detection of the COVID-19 virus, globally.

The major driving factor behind the growth of the DNA/RNA extraction kit market is the increasing investments in R&D activities in different fields, including molecular diagnostics for different chronic and infectious diseases. For example, according to the Organization for Economic Co-operation and Development, in 2018, the United States spent USD 552 billion on R&D activities, followed by China with USD 463 billion. The technological advancements, the launch of new products by the key market players, and rising cases of cancer, worldwide, may also complement the growth of the market studied. For instance, in June 2020, Omega Bio-tek Inc. announced the launch of an advanced viral RNA extraction kit for the COVID-19 testing, called Mag-Bind Viral RNA Xpress kit, for the efficient extraction of the Viral RNA from nasopharyngeal (NP) swab samples.

Other factors, such as increased demand in the automation of DNA/RNA extraction technology, new user-friendly and easy extraction kits, use of DNA/RNA in the profiling of new diseases causing microorganisms, are expected to boost the growth of the DNA/RNA extraction kit market during the forecast period. Thus, the low awareness and availability of the kits and less market penetration in the underdeveloped and developing regions, worldwide, are the major restraining factors for the growth of the DNA/RNA extraction kit market.

Scope of the Report

The DNA/RNA extraction kits are used for isolating the DNA or RNA from any cell, which can be from any animal, microbe, or plant. The primary use of these extractions is for DNA or RNA profiling of various organisms to better understand and sometimes to identify the unknown organism. The global DNA/RNA extraction kit market is segmented by product (cell-free DNA, sequence-specific DNA, sequence-specific RNA, total RNA, and other products), application (hospitals, diagnostics centers, and research institutions), and geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America).

By Product
Cell Free DNA
Sequence Specific DNA
Sequence Specific RNA
Total RNA
Other Products
By End Users
Hospitals
Diagnostics Centers
Research Institutions
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Extraction Kits for Cancer Patients for Diagnosis and Identification Will Occupy a Significant Share in the Market over the Forecast Period

A patient suffering from any kind of cancer, circulating cell-free DNA (ccfDNA), which originates from cancer cells, is found in the bloodstream, known as circulating tumor DNA (ctDNA). A very sensitive RNA and DNA extraction kits are used to isolate and profile them based on which treatment is performed on the patient. The companies are working toward it and developing and launching products related to the area. For instance, in May 2018, BioChain Institute Inc. launched a new cell-free DNA extraction kit, cfPure, for the efficient isolation and detection of circulating cell-free DNA (ccfDNA).

According to the International Agency for Research on Cancer (IARC) data released in December 2020, about 1 in 5 people develops cancer in their lifetime, and 1 in 8 men and 1 in 11 women die from cancer, globally. As per its updated GLOBOCAN 2020 report, in 2020, approximately 19.3 million new cancer cases were registered, worldwide, and 10 million people died from it. Therefore, the increasing prevalence of cancer may boost the growth of the DNA/RNA extraction kit market.

Global

North America is Expected to Dominate the Global DNA/RNA Extraction Kit Market During the Forecast Period

North America holds a major share of the DNA/RNA extraction kit market and is expected to show a similar trend over the forecast period, mainly due to high R&D activities in the region, along with the presence of key market players in the area who are continuously evolving their product offering for the market studied.

In the region, the United States is expected to occupy the major share in the DNA/RNA extraction kit market due to huge investment in R&D by the government and private entities, increasing demand for the kits, and rising prevalence of chronic diseases, such as cancer. As per the GLOBOCAN 2020 report, around 2,281,658 new cancer cases in the United States were registered, and 612,390 patients died due to it. Additionally, the new product launches and other expansion initiatives of the market by the key market players in the area may boost the growth of the DNA/RNA extraction kit market. For instance, in February 2020, Promega Corporation announced the launch of a new DNA extraction kit, known as Wizard HMW DNA Extraction Kit, for extracting large fragments of DNA from any biological sample.

Regional

Competitive Landscape

The DNA/RNA extraction kit market will be very competitive due to the presence of different market players in all parts of the world, both local and multinational. The efficient and user-friendly kit may be in huge demand in the future, and the major driving force may be new developments and innovations in the following segment. The major market players of the DNA and RNA extraction kit market are as follows: Qiagen, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, F Hoffmann-La Roche AG, bioMérieux SA, and several others.

Recent Developments

  • In October 2020, Purigen Biosystems Inc. announced the launch of a DNA extraction kit for the researchers working with limited biological samples, called Ionic Cells to Pure DNA Low Input Kit.
  • In July 2020, the Indian Institute of Technology developed the world’s cheapest RNA-based COVID-19 testing kit for commercial use, which was approved by the Indian Council of Medical Research.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Investments in R&D of Molecular Diagnostics

      2. 4.2.2 Technological Advancements

      3. 4.2.3 Increasing Prevalence of Cancer Cases

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness About the Kits

      2. 4.3.2 Low Market Penetration

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Buyers/Consumers

      2. 4.4.2 Bargaining Power of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Cell Free DNA

      2. 5.1.2 Sequence Specific DNA

      3. 5.1.3 Sequence Specific RNA

      4. 5.1.4 Total RNA

      5. 5.1.5 Other Products

    2. 5.2 By End Users

      1. 5.2.1 Hospitals

      2. 5.2.2 Diagnostics Centers

      3. 5.2.3 Research Institutions

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Qiagen

      2. 6.1.2 ThermoFisher Scientific Inc.

      3. 6.1.3 F Hoffmann-La Roche AG

      4. 6.1.4 Agilent Technologies

      5. 6.1.5 Bio-Rad Laboratories Inc.

      6. 6.1.6 Promega Corporation

      7. 6.1.7 Danaher Corporation (Beckman Coulter Inc.)

      8. 6.1.8 Merck & Co. Inc.

      9. 6.1.9 PerkinElmer Inc.

      10. 6.1.10 bioMérieux SA

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments in that box

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global DNA/RNA Extraction Kit Market market is studied from 2018 - 2026.

The Global DNA/RNA Extraction Kit Market is growing at a CAGR of 7.26% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Qiagen, Agilent, Bio-Rad Laboratories, Promega Corporation, F Hoffmann-La Roche AG are the major companies operating in Global DNA/RNA Extraction Kit Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!